Narbey et al reported an algorithm for transfusing a patient with sickle cell disease. This can help to guide patient management. The authors are from multiple institutions in France.
Patient selection: sickle cell disease
Goal: prescription of an occasional transfusion
Parameters for a predictive score:
(1) history of significant antibodies
(2) history of non-significant antibodies and/or anti-Rh and/or anti-K
(3) number of previous transfused units
(4) history of delayed hemolytic transfusion reaction (DHTR)
Parameter |
Finding |
Poitns |
history of significant antibody |
no |
0 |
|
yes |
6 |
history of nonsignificant antibodies or anti-Rh/K |
no |
0 |
|
yes |
5 |
number of previous transfusions |
< 12 |
8 |
|
>= 12 |
0 |
history of DHTR |
no |
0 |
|
yes |
5 |
where:
• The patient with no history of transfusion has a high rate of DHTR. A patient who has received multiple units is at a lower risk for DHTR (page 1346, column 1).
total score =
= SUM(points for all 4 parameters)
Interpretation:
• minimum score: 0
• maximum score 24
Status |
Score < 8 |
Score >= 8 |
no previous immunization |
match for Rh and K |
match for Rh and K; extended crossmatch |
only anti-Rh and/or anti-K |
match for Rh and K |
match for Rh and K; extended crossmatch |
significant antibodies |
match for Rh and K; match for antibody specificity; if possible perform an extended crossmatch |
match for Rh and K; extended match; rituximab therapy |
Specialty: Clinical Laboratory, Hematology Oncology